Glythera Technology
Glythera's objective is to improve the therapeutic potential of protein and peptide based drugs through the use of our proprietary Linker and Glycosylation technologies.
Intellectual Property
Glythera values the need to protect its IP and conducts reviews of prior art through its patent agents. Glythera has filed 3 patent families with designated territories world-wide and aims to add to this portfolio, during the development of its products. The current patents are unpublished but available under Confidentiality Agreements.
Glythera's objective is to improve the therapeutic potential of protein and peptide based drugs through the use of our proprietary Linker and Glycosylation technologies.
Intellectual Property
Glythera values the need to protect its IP and conducts reviews of prior art through its patent agents. Glythera has filed 3 patent families with designated territories world-wide and aims to add to this portfolio, during the development of its products. The current patents are unpublished but available under Confidentiality Agreements.